While the main factor contributing to age at onset is the length of the CAG repeat, genetic modifiers have been identified in SCA3 (de Mattos et al., 2019; Raposo et al., 2022; Weber et al., 2024), including the APOE genotype. This evidence concerns the gene APOE and Spinocerebellar ataxia type 3.